Fig. 6
From: Mackinawite nanozymes as reactive oxygen species scavengers for acute kidney injury alleviation
Evaluation of kidney function after GFeSN treatment. a Schematic for construction of AKI model mice and their treatment with GFeSNs. b Representative kidney samples from each group. c CRE levels in blood of mice after different treatments (n = 5). d BUN levels in mice after different treatments (n = 5). e Percentage of mouse survival under different treatments (n = 5). f Blood iron content in PBS- and GFeSN-treated mice at indicated time points post injection (n = 3). Body weight curves of PBS-treated healthy mice (g), healthy mice with intravenous injection of GFeSNs (h), AKI mice (i), and AKI mice with intravenous injection of GFeSNs (j) (n = 5). Error bars are mean ± SD (****p < 0.0001)